Comparison of Anti-Glycation Capacity of Two New Purple-Colored-Leaf Tea Cultivars with an Ordinary Green-Colored-Leaf Tea Cultivar in Taiwan
Journal Title: Global Journal of Obesity, Diabetes and Metabolic Syndrome - Year 2017, Vol 4, Issue 1
Abstract
The special tea varieties with purple- or red-colored leaves have been successfully bred in Taiwan and their health benefits are needed to be evaluated. The aim of this study was to evaluate the phytochemical content, the antioxidant properties, and the anti-glycation capacities of two new purple-colored-leaf tea cultivars (TTES No.113 & 117) and one of the most cultivated teas in Taiwan (TTES No.18). Green tea made from the two purple-colored-leaf tea cultivars, especially the TTES No.117 had significantly higher phenolic, flavonoid, anthocyanin, and catechin content than the TTES No.18. The purple-colored-leaf tea also had higher antioxidant activities including ferric reducing antioxidant power (FRAP) and oxygen radical absorbance capacity (ORAC). The formation of fluorescent advanced glycation end products (AGEs) and non-fluorescent AGEs (Nɛ-carboxymethyllysine; CML) in a glucose/ BSA system were significantly inhibited by teas. The inhibitory capacities of teas on fluorescent AGEs and CML were correlated with phenolics or flavonoids, rather than catechins or anthocyanins. These results implied that the potent antiglycation capacity of purple-colored-leaf tea was primarily attributed to the total phenolics. These findings highlight that the potential use of purple-colored-leaf tea bred in Taiwan as a functional beverage for preventing diabetic complications.
Authors and Affiliations
Ho Su-Chen, Su Min-Sheng, Lin Chih-Cheng, Chiu Chui-Feng
Keywords
Related Articles
- EP ID EP343836
- DOI 10.17352/2455-8583.000017
- Views 108
- Downloads 0
Reversible blindness associated with severe Diabetic Ketoacidosis
Diabetes mellitus is commonly associated with gradual onset of visual loss. Reversible acute blindness associated with diabetic ketoacidosis has been reported only once previously .Metformin associated blindness is commo...
Nutrigenomics Coupling with other OMICS Platform Enhance Personalized Health Care in Metabolic Disorders
Diabetes is a multifactorial of diseases characterized by high blood glucose levels which occur as a result in the body’s inability to produce and/or use insulin. Both type 1 and 2 diabetes are thought to be complex dise...
The Metabolic Syndrome in Hispanics – The Role of Inflammation
We report clinical and molecular mechanisms relating the pro-inflammatory and anti-inflammatory process in the development of the components of the metabolic syndrome, emphasizing the cardiovascular problems developed in...
Blood Catalase Activities, Catalase Gene Polymorphisms and Acatalasemia Mutations in Hungarian Patients with Diabetes Mellitus
Introduction: Catalase decomposes hydrogen peroxide into oxygen and water. Its low concentration could be involved in signaling while its high concentration is toxic. Aim: This short review discusses the association of b...
Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy
The association between Diabetes and cancer has been known for decades with obesity and insulin resistance being postulated as the main underlying risk factors for both disorders. With rise of the epidemic of obesity in...